Company Filing History:
Years Active: 2013-2018
Title: Andrew Malcolm Nesbitt: Innovator in Antibody Molecules
Introduction
Andrew Malcolm Nesbitt is a notable inventor based in Slough, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules. With a total of 3 patents to his name, Nesbitt's work has the potential to impact therapeutic applications significantly.
Latest Patents
Nesbitt's latest patents focus on antibody molecules that have specificity for human OX40. The invention relates to antibody molecules that target antigenic determinants of human OX40, along with their therapeutic uses and methods for producing these antibody molecules. This innovative work aims to enhance treatment options for various medical conditions.
Career Highlights
Throughout his career, Andrew Malcolm Nesbitt has worked with prominent companies in the pharmaceutical industry, including UCB Pharma and UCB Biopharma. His experience in these organizations has allowed him to develop and refine his expertise in antibody research and development.
Collaborations
Nesbitt has collaborated with several professionals in his field, including Alastair David Griffiths Lawson and Andrew George Popplewell. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Andrew Malcolm Nesbitt is a distinguished inventor whose work in antibody molecules showcases his commitment to advancing medical science. His contributions have the potential to lead to significant therapeutic advancements in healthcare.